Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial

被引：0

作者：

Meng, Xiangrui ^{[1
]}

Qi, Yu ^{[1
]}

Shan, Zhengzheng ^{[1
]}

Yang, Yang ^{[1
]}

Fan, Qingxia ^{[1
]}

Wang, Feng ^{[1
]}

机构：

[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16087

引用

页数：1

共 50 条

[21] A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Wang, J.
He, M.
Yao, J.
Cheng, Y.
Wu, Y.
ANNALS OF ONCOLOGY, 2020, 31 : S931 - S931
[22] Camrelizumab plus apatinib successfully treated a patient with advanced esophageal squamous cell carcinoma
Yan, Zheng
Yao, Zhi-Hua
Yao, Shu-Na
Wang, Hai-Ying
Chu, Jun-Feng
Song, Ming
Zhao, Shuang
Liu, Yan-Yan
IMMUNOTHERAPY, 2020, 12 (16) : 1161 - 1166
[23] A Phase II Clinical Trial of Sintilimab Combined with Lower Dose Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Liu, Y.
Chen, Y.
Yu, R.
Zou, B.
Zhou, X.
Gong, Y.
Peng, F.
Hu, Y.
Wang, W.
Yuan, Y.
Chen, L.
Tian, D.
Yu, M.
Li, Y.
Lu, Y.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E433 - E434
[24] Neoadjuvant Versus Adjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
Zhu, Y.
Sun, X.
Wu, L.
Chen, Q.
Wei, Q.
Ye, P.
Han, S.
Yu, X.
Liu, J.
Zhao, Q.
Jiang, Y.
Zhou, X.
Zhang, W.
Mao, W.
Xu, Y.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S51 - S51
[25] Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial
Lin, Jian-Xian
Tang, Yi-Hui
Zheng, Hua-Long
Ye, Kai
Cai, Jian-Chun
Cai, Li-Sheng
Lin, Wei
Xie, Jian-Wei
Wang, Jia-Bin
Lu, Jun
Chen, Qi-Yue
Cao, Long-Long
Zheng, Chao-Hui
Li, Ping
Huang, Chang-Ming
NATURE COMMUNICATIONS, 2024, 15 (01)
[26] Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial
Jian-Xian Lin
Yi-Hui Tang
Hua-Long Zheng
Kai Ye
Jian-Chun Cai
Li-Sheng Cai
Wei Lin
Jian-Wei Xie
Jia-Bin Wang
Jun Lu
Qi-Yue Chen
Long-Long Cao
Chao-Hui Zheng
Ping Li
Chang-Ming Huang
Nature Communications, 15 (1)
[27] Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study
Sheng, Yinliang
Meng, Xiangrui
Zhang, Chunyang
Shan, Zhengzheng
Li, Feng
Wu, Bin
Xu, Mengli
Li, Aijia
Guan, Lulu
Chen, Lidong
Sun, Shuzhen
Ma, Yihui
Lu, Taiying
Zhao, Song
Fan, Qingxia
Qi, Yu
Wang, Feng
JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5337 - 5347
[28] Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?
Liu, Jiacong
Zhu, Linhai
Huang, Xuhua
Lu, Zhongjie
Wang, Yanye
Yang, Yuhong
Ye, Jiayue
Gu, Chen
Lv, Wang
Zhang, Chong
Hu, Jian
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
[29] Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?
Jiacong Liu
Linhai Zhu
Xuhua Huang
Zhongjie Lu
Yanye Wang
Yuhong Yang
Jiayue Ye
Chen Gu
Wang Lv
Chong Zhang
Jian Hu
Journal of Cancer Research and Clinical Oncology, 150
[30] Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial
Wu, Zixiang
Wu, Chuanqiang
Zhao, Jing
Wu, Cong
Peng, Haixian
Wang, Qi
Bai, Rui
Fang, Xuefeng
He, Hong
Shen, Hong
Wu, Ming
ECLINICALMEDICINE, 2024, 71

← 1 2 3 4 5 →